By Associate Professor James Robert Bell

Journal articles

Rodgers C; Siefried KJ; Ritter A; Belackova V; Treloar C; Jauncey M; Ezard N; Roberts D; Steele M; van den Brink W; Strang J; Oviedo-Joekes E; Lintzeris N; Dunlop AJ; Bell J, 2024, 'Implementation of time-limited parenteral hydromorphone in people with treatment-resistant injecting opioid use disorder: a protocol for a single-site, uncontrolled, open-label study to assess feasibility, safety and cost', BMJ Open, 14, http://dx.doi.org/10.1136/bmjopen-2023-082553

Bell J, 2022, 'What are the considerations in the pharmacological management of opioid addiction in adolescents?', Expert Opinion on Pharmacotherapy, 23, pp. 155 - 157, http://dx.doi.org/10.1080/14656566.2021.1998456

Nielsen S; Sanfilippo P; Belackova V; Day C; Silins E; Lintzeris N; Bruno R; Grebely J; Lancaster K; Ali R; Bell J; Dietze P; Degenhardt L; Farrell M; Larance B, 2021, 'Perceptions of injectable opioid agonist treatment (iOAT) among people who regularly use opioids in Australia: findings from a cross-sectional study in three Australian cities', Addiction, 116, pp. 1482 - 1494, http://dx.doi.org/10.1111/add.15297

Tas B; Jolley CJ; Kalk NJ; van der Waal R; Bell J; Strang J, 2020, 'Heroin-induced respiratory depression and the influence of dose variation: within-subject between-session changes following dose reduction', Addiction, 115, pp. 1954 - 1959, http://dx.doi.org/10.1111/add.15014

Bell J; Strang J, 2020, 'Medication Treatment of Opioid Use Disorder', Biological Psychiatry, 87, pp. 82 - 88, http://dx.doi.org/10.1016/j.biopsych.2019.06.020

Belackova V; Salmon AM; Jauncey M; Bell J, 2019, 'Learning from the past, looking to the future - Is there a place for injectable opioid treatment among Australia's responses to opioid misuse?', International Journal of Drug Policy, 71, pp. 164 - 168, http://dx.doi.org/10.1016/j.drugpo.2019.01.026

Reed K; Knight A; Baillie S; Bogdanowicz K; Bell J; Strang J, 2018, 'Switching between lyophilized and sub-lingual buprenorphine formulations in opioid-dependent patients: Observations on medication transfer during a safety and pharmacokinetic study', Heroin Addiction and Related Clinical Problems, 20, pp. 19 - 28

Bell J; Belackova V; Lintzeris N, 2018, 'Supervised Injectable Opioid Treatment for the Management of Opioid Dependence', Drugs, 78, pp. 1339 - 1352, http://dx.doi.org/10.1007/s40265-018-0962-y

Strang J; Knight A; Baillie S; Reed K; Bogdanowicz K; Bell J, 2018, 'Norbuprenorphine and respiratory depression: Exploratory analyses with new lyophilized buprenorphine and sublingual buprenorphine', International Journal of Clinical Pharmacology and Therapeutics, 56, pp. 81 - 85, http://dx.doi.org/10.5414/CP203118

Bell J; Waal RVD; Strang J, 2017, 'Supervised Injectable Heroin: A Clinical Perspective', Canadian Journal of Psychiatry, 62, pp. 451 - 456, http://dx.doi.org/10.1177/0706743716673966

Dunlop AJ; Brown AL; Oldmeadow C; Harris A; Gill A; Sadler C; Ribbons K; Attia J; Barker D; Ghijben P; Hinman J; Jackson M; Bell J; Lintzeris N, 2017, 'Effectiveness and cost-effectiveness of unsupervised buprenorphine-naloxone for the treatment of heroin dependence in a randomized waitlist controlled trial', Drug and Alcohol Dependence, 174, pp. 181 - 191, http://dx.doi.org/10.1016/j.drugalcdep.2017.01.016

Strang J; Reed K; Bogdanowicz K; Bell J; Van Der Waal R; Keen J; Beavan P; Baillie S; Knight A, 2017, 'Randomised Comparison of a Novel Buprenorphine Oral Lyophilisate versus Existing Buprenorphine Sublingual Tablets in Opioid-Dependent Patients: A First-in-Patient Phase II Randomised Open Label Safety Study', European Addiction Research, 23, pp. 61 - 70, http://dx.doi.org/10.1159/000456612

Bell J, 2017, 'Commentary on Nikoo et al. (2017): The role of research', Addiction, 112, pp. 430 - 431, http://dx.doi.org/10.1111/add.13704

Bell J, 2016, 'Alcohol use disorders', Medicine (United Kingdom), 44, pp. 697 - 700, http://dx.doi.org/10.1016/j.mpmed.2016.09.001

van Amsterdam J; Phillips L; Henderson G; Bell J; Bowden-Jones O; Hammersley R; Ramsey J; Taylor P; Dale-Perera A; Melichar J; van den Brink W; Nutt D, 2015, 'Ranking the harm of non-medically used prescription opioids in the UK', Regulatory Toxicology and Pharmacology, 73, pp. 999 - 1004, http://dx.doi.org/10.1016/j.yrtph.2015.09.014

Jolley CJ; Bell J; Rafferty GF; Moxham J; Strang J, 2015, 'Understanding heroin overdose: A study of the acute respiratory depressant effects of injected pharmaceutical heroin', PLoS ONE, 10, http://dx.doi.org/10.1371/journal.pone.0140995

Strang J; Groshkova T; Uchtenhagen A; Van Den Brink W; Haasen C; Schechter MT; Lintzeris N; Bell J; Pirona A; Oviedo-Joekes E; Simon R; Metrebian N, 2015, 'Heroin on trial: Systematic review and meta-analysis of randomised trials of diamorphine-prescribing as treatment for refractory heroin addiction', British Journal of Psychiatry, 207, pp. 5 - 14, http://dx.doi.org/10.1192/bjp.bp.114.149195

Lee CH; Wang TJ; Tang HP; Liu YH; Bell J, 2015, 'Familial expressed emotion among heroin addicts in methadone maintenance treatment: Does it matter?', Addictive Behaviors, 45, pp. 39 - 44, http://dx.doi.org/10.1016/j.addbeh.2015.01.014

Jolley CJ; Bell J; Rafferty GF; Moxham J; Strang J, 2015, 'S50 Understanding Heroin Overdose: A Study of the Acute Respiratory Depressant Effects of Injected Pharmaceutical Heroin', Thorax, 70, pp. A31.2 - A32, http://dx.doi.org/10.1136/thoraxjnl-2015-207770.56

Bell J, 2014, 'Addiction and recovery', BMJ (Online), 349, http://dx.doi.org/10.1136/bmj.g6880

Bell J, 2014, 'Pharmacological maintenance treatments of opiate addiction', British Journal of Clinical Pharmacology, 77, pp. 253 - 263, http://dx.doi.org/10.1111/bcp.12051

Winstock AR; Borschmann R; Bell J, 2014, 'The non-medical use of tramadol in the UK: Findings from a large community sample', International Journal of Clinical Practice, 68, pp. 1147 - 1151, http://dx.doi.org/10.1111/ijcp.12429

Winstock A; Bell J; Borschmann R, 2013, 'Friends, doctors, and tramadol: We might have a problem', BMJ (Online), 347, http://dx.doi.org/10.1136/bmj.f5599

Bell J, 2013, 'Commentary on Krupitsky etal.(2013): Refuge from the streets-parked on methadone, or seeking shelter of a depot?', Addiction, 108, pp. 1638 - 1639, http://dx.doi.org/10.1111/add.12248

Gomes M; Aldridge RW; Wylie P; Bell J; Epstein O, 2013, 'Cost-effectiveness analysis of 3-D computerized tomography colonography versus optical colonoscopy for imaging symptomatic gastroenterology patients', Applied Health Economics and Health Policy, 11, pp. 107 - 117, http://dx.doi.org/10.1007/s40258-013-0019-z

Bell J; Healey C; Kennedy F; Faizal M; Shah AJ, 2013, 'Evidence and recovery; improving outcomes in opiate substitution treatment', British Journal of Medical Practitioners, 6

Bell J; Kilic C; Prabakaran R; Wang YY; Wilson R; Broadbent M; Kumar A; Curtis V, 2013, 'Use of electronic health records in identifying drug and alcohol misuse among psychiatric in-patients', Psychiatrist, 37, pp. 15 - 20, http://dx.doi.org/10.1192/pb.bp.111.038240

Bell J, 2012, 'Alcohol use disorders', Medicine (United Kingdom), 40, pp. 637 - 639, http://dx.doi.org/10.1016/j.mpmed.2012.09.008

Bell J; Bowler S; Lyons J, 2012, 'Emergency care. Urgent issues of alcohol overload.', The Health service journal, 122, pp. 26 - 27

Bell J, 2012, 'Buprenorphine in the treatment of heroin addiction', Dusunen Adam - The Journal of Psychiatry and Neurological Sciences, 25, pp. 93 - 100, http://dx.doi.org/10.5350/DAJPN20122502001

Larance B; Degenhardt L; O'Brien S; Lintzeris N; Winstock A; Mattick RP; Bell J; Ali R, 2011, 'Prescribers' perceptions of the diversion and injection of medication by opioid substitution treatment patients', Drug and Alcohol Review, 30, pp. 613 - 620, http://dx.doi.org/10.1111/j.1465-3362.2010.00274.x

Webzell I; Ball D; Bell J; Sherwood RA; Marsh A; O'Grady JG; Heaton ND, 2011, 'Substance use by liver transplant candidates: An anonymous urinalysis study', Liver Transplantation, 17, pp. 1200 - 1204, http://dx.doi.org/10.1002/lt.22370

Bell J, 2011, 'Commentary on Reimer etal. (2011): More work needed', Addiction, 106, pp. 1656 - 1657, http://dx.doi.org/10.1111/j.1360-0443.2011.03557.x

Bell J, 2011, 'Your guide to today's mental health issues. Managing drug problems.', Mental health today (Brighton, England), pp. 25 - 27

Bell J; Collins R, 2011, 'Gamma-butyrolactone (GBL) dependence and withdrawal', Addiction, 106, pp. 442 - 447, http://dx.doi.org/10.1111/j.1360-0443.2010.03145.x

Dean A; Saunders JB; Bell JR, 2011, 'Heroin use, dependence, and attitudes to treatment in non-treatment-seeking heroin users: a pilot study', Substance Use and Misuse, 46, pp. 417 - 425, http://dx.doi.org/10.3109/10826084.2010.501655

Shearer J; Mammen K; BELL J, 2010, 'The acceptability of combined methadone-naloxone treatment: Consumer and provider views on the potential utility of methadone-naloxone', Drug and Alcohol Review, 29, pp. 138 - 143, http://dx.doi.org/10.1111/j.1465-3362.2009.00118.x

Mammen K; Bell J, 2009, 'The clinical efficacy and abuse potential of combination buprenorphine-naloxone in the treatment of opioid dependence', Expert Opinion on Pharmacotherapy, 10, pp. 2537 - 2544, http://dx.doi.org/10.1517/14656560903213405

White J; Bell J; Saunders JB; Williamson P; Makowska M; Farquharson A; Beebe KL, 2009, 'Open-label dose-finding trial of buprenorphine implants (Probuphine)^® for treatment of heroin dependence', Drug and Alcohol Dependence, 103, pp. 37 - 43, http://dx.doi.org/10.1016/j.drugalcdep.2009.03.008

Bell J; Shearer J; Ryan A; Graham R; Korompay K; Rizzo S; Sindhusake D; Somogyi AA, 2009, 'The Acceptability, Safety, and Tolerability of Methadone/Naloxone in a 50: 1 Ratio', Experimental and Clinical Psychopharmacology, 17, pp. 146 - 153, http://dx.doi.org/10.1037/a0016302

Bell JR; Trinh L; Butler B; Randall D; Rubin GL, 2009, 'Comparing retention in treatment and mortality inpeople after initial entry to methadone andbuprenorphine treatment', Addiction, pp. 1193 - 1200

Bell J; Harvey-Dodds L, 2008, 'Pregnancy and injecting drug use', BMJ, 336, pp. 1303 - 1305, http://dx.doi.org/10.1136/bmj.39514.554375.AE

Bell J; Butler B, 2008, 'Health care utilization and morbidity associated with methadone and buprenorphine treatment', Heroin Addiction and Related Clinical Problems, 10, pp. 21 - 26

Bell JR; Ryan A; Mutch C; Batey RG; Rea F, 2008, 'Optimising the benefits of unobserved dose administration for stable opioid maintenance patients: Follow-up of a randomised trial', Drug and Alcohol Dependence, 96, pp. 183 - 186

Bell JR, 2008, 'Speciality recognition of addiction medicine in Australia', Addiction, 103, pp. 701 - 702, http://dx.doi.org/10.1111/j.1360-0443.2007.02121.x

Ryan G; Lyon P; Kumar K; Bell J; Barnet S; Shaw T, 2007, 'Online CME: An effective alternative to face-to-face delivery', Medical Teacher, 29, http://dx.doi.org/10.1080/01421590701551698

Bose M; Bell J; Jackson L; Casey P; Saunders J; Epstein O, 2007, 'Virtual vs. optical colonoscopy in symptomatic gastroenterology out-patients: The case for virtual imaging followed by targeted diagnostic or therapeutic colonoscopy', Alimentary Pharmacology and Therapeutics, 26, pp. 727 - 736, http://dx.doi.org/10.1111/j.1365-2036.2007.03414.x

Bell J; Zador D, 2007, 'Dihydrocodeine as effective as methadone for maintenance of treatment for opiate dependence? Commentary', Evidence-Based Mental Health, 10, pp. 88, http://dx.doi.org/10.1136/ebmh.10.3.88

Milne B; Bell J; Lampropoulos B; Towns S, 2007, 'Alcohol, drugs and Australian young people', International Journal of Adolescent Medicine and Health, 19, pp. 245 - 253, http://dx.doi.org/10.1515/IJAMH.2007.19.3.245

Bell J; Burrell T, 2006, 'Retention and attendance with supervised buprenorphine treatment: A case-note review', Drug and Alcohol Review, 25, pp. 161 - 165, http://dx.doi.org/10.1080/09595230500537647

Back to profile page